Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


September 04, 2015 4:19 AM ET

Biotechnology

Company Overview of Microvi Biotechnologies Inc.

Company Overview

Microvi Biotechnologies Inc., a biotechnology company, discovers, develops, manufactures, and commercializes bio-catalytic solutions in water, energy, and chemical industries. The company’s technology include MicroNiche Engineering, a science of synthetically designing the microenvironment of a biological system to optimize enzymatic processes used in producing clean water, sustainable fuels, and bio-based chemicals. It serves private, public, or academic organizations. The company was founded in 2004 and is based in Hayward, California.

26229 Eden Landing Road

Hayward, CA 94545

United States

Founded in 2004

Phone:

510-344-0668

Fax:

801-443-5137

Key Executives for Microvi Biotechnologies Inc.

Founder, Chief Executive Officer, Chief Technology Officer and Director
Senior Vice President of Legal and Intellectual Property
Director of Marketing
Compensation as of Fiscal Year 2015.

Microvi Biotechnologies Inc. Key Developments

Microvi Biotech Inc. Presents at World Congress on Industrial Biotechnology, May-12-2014

Microvi Biotech Inc. Presents at World Congress on Industrial Biotechnology, May-12-2014 . Venue: Philadelphia, Pennsylvania, United States.

National Institute of Environmental Health Sciences Awards Microvi Biotech Inc. $1.5 Million Phase II Grant for Demonstration of 1,4-Dioxane Degradation Technology

Microvi Biotech Inc. announced that it has been awarded a $1.5 million grant from the National Institute of Environmental Health Sciences (NIEHS) to demonstrate at scale a novel technology for the treatment of 1,4 dioxane in water. This follows on the success of work completed during the Phase I grant, where a prototype was developed and tested of a first-of-its-kind biological treatment technology for dioxane degradation called MB-DX(TM).

Similar Private Companies By Industry

Company Name Region
L1 AgroSciences, Inc. United States
Vindico NanoBioTechnology, Inc. United States
Natural Chem Group LLC United States
Pelican Therapeutics, Inc. United States
Elusys Therapeutics, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
January 20, 2015
--
Private Placement
November 7, 2014
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Microvi Biotechnologies Inc., please visit www.microvi.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.